Iasibon

Iasibon

Marketed minn: Pharmathen S.A.
Ingredjent attiv: ibandronic acid

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Ibandronic Acid Accord

Ibandronic Acid Accord

Marketed minn: Accord Healthcare S.L.U.
Ingredjent attiv: ibandronic acid

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Ibandronic Acid Sandoz

Ibandronic Acid Sandoz

Marketed minn: Sandoz GmbH
Ingredjent attiv: ibandronic acid

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Ibandronic Acid Teva

Ibandronic Acid Teva

Marketed minn: Teva Pharma B.V.
Ingredjent attiv: ibandronic acid

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Iblias

Iblias

Marketed minn: Bayer AG
Ingredjent attiv: octocog alfa

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Ibrance

Ibrance

Marketed minn: Pfizer Europe MA EEIG 
Ingredjent attiv: palbociclib

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Icandra (previously Vildagliptin / Metformin Hydrochloride Novartis)

Icandra (previously Vildagliptin / Metformin Hydrochloride Novartis)

Marketed minn: Novartis Europharm Limited
Ingredjent attiv: vildagliptin, metformin hydrochloride

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Iclusig

Iclusig

Marketed minn: Incyte Biosciences Distribution B.V.
Ingredjent attiv: ponatinib

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Idelvion

Idelvion

Marketed minn: CSL Behring GmbH
Ingredjent attiv: albutrepenonacog alfa

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Idflu

Idflu

Marketed minn: Sanofi Pasteur S.A.
Ingredjent attiv: virus tal-influwenza (inattivat, maqsuma) tar-razez li ġejjin:/California/7/2009 (H1N1)pdm09 - like strain (A/California/7/2009, NYMC X-179A)A/Hong Kong/4801/2014 (H3N2) like strain (A/Hong Kong/4801/2014, NYMC X-263B)B/Brisbane/60/2008 - like strain (B/Brisbane/60/2008, tat-tip selvaġġ)

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Ifirmacombi

Ifirmacombi

Marketed minn: Krka, d.d., Novo mesto
Ingredjent attiv: irbesartan, hydrochlorothiazide

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Ifirmasta (previously Irbesartan Krka)

Ifirmasta (previously Irbesartan Krka)

Marketed minn: Krka, d.d., Novo mesto
Ingredjent attiv: irbesartan hydrochloride

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Ikervis

Ikervis

Marketed minn: Santen Oy
Ingredjent attiv: ciclosporin

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Ilaris

Ilaris

Marketed minn: Novartis Europharm Limited
Ingredjent attiv: Canakinumab

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Imatinib Accord

Imatinib Accord

Marketed minn: Accord Healthcare S.L.U.
Ingredjent attiv: imatinib

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Imatinib Actavis

Imatinib Actavis

Marketed minn: Actavis Group PTC ehf
Ingredjent attiv: imatinib

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Imatinib Medac

Imatinib Medac

Marketed minn: Medac
Ingredjent attiv: imatinib

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Imatinib Teva

Imatinib Teva

Marketed minn: Teva B.V.
Ingredjent attiv: imatinib

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Imbruvica

Imbruvica

Marketed minn: Janssen-Cilag International NV
Ingredjent attiv: Ibrutinib

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Imlygic

Imlygic

Marketed minn: Amgen Europe B.V.
Ingredjent attiv: talimogene laherparepvec

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Immunogam

Immunogam

Marketed minn: Cangene Europe Limited
Ingredjent attiv: immunoglobulina tal-epatite B umana

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Imnovid (previously Pomalidomide Celgene)

Imnovid (previously Pomalidomide Celgene)

Marketed minn: Celgene Europe B.V. 
Ingredjent attiv: Pomalidomide

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Imprida

Imprida

Marketed minn: Novartis Europharm Ltd
Ingredjent attiv: amlodipine (bħala besylate), valsartan

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Imprida Hct

Imprida Hct

Marketed minn: Novartis Europharm Ltd.
Ingredjent attiv: l-amlodipina, valsartan, hydrochlorothiazide

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Imvanex

Imvanex

Marketed minn: Bavarian Nordic A/S
Ingredjent attiv: vaċċin immodifikat Ankara - il-virus Bavarian Nordic (MVA-BN)

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Incivo

Incivo

Marketed minn: Janssen-Cilag International N.V.
Ingredjent attiv: telaprevir

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Increlex

Increlex

Marketed minn: Ipsen Pharma
Ingredjent attiv: Mecasermin

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Incresync

Incresync

Marketed minn: Takeda Pharma A/S
Ingredjent attiv: alogliptin, pioglitazone

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Incruse Ellipta (previously Incruse)

Incruse Ellipta (previously Incruse)

Marketed minn: GlaxoSmithKline (Ireland) Limited
Ingredjent attiv: umeclidinium bromide

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Inductos

Inductos

Marketed minn: Medtronic BioPharma B.V.
Ingredjent attiv: dibotermin alfa

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency